Search Within

Department of Medicine

Formats
  1. Journal Article (19596)
  2. Meeting Abstract (16046)
  3. Review (1154)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (297)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22330)
  2. Hematologic Malignancies, Division of (13280)
  3. Center for Hematologic Malignancies (11063)
  4. GSK Faculty (10648)
  5. Survivorship Research (9336)
  6. Division of Subspecialty Medicine (7544)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1088)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2287)
  6. Nature Publishing Group (2111)

More Publishers

Results (39639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A composite assessment method for evaluating CTCL
    Meeting Abstract

    Myskowski, P.; Washenik, K.; Stevens, V.; Yocum, R.
    Journal of Investigative Dermatology (2000)

    Fulltext@MSK | Save
  • Association of DNA damage/repair deficiency with melanoma
    Meeting Abstract

    Berwick, M.; Song, Y.; Roy, P.; Mahabir, S.; Elahi, A.; Coit, D.; Lewis, J.; Halpern, A.; Myskowski, P.; Brady, M.; more...
    Journal of Investigative Dermatology (2000)

    Fulltext@MSK | Save
  • Ototoxicity following combined modality therapy for nasopharyngeal carcinoma
    Meeting Abstract

    Choi, S. L.; Wolden, S. L.; Pfister, D. G.; Budnick, A. S.; Levegrun, S.; Jackson, A.; Hunt, M. A.; Zelefsky, M. J.; Singh, B.; Boyle, J. O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2000)

    Fulltext@MSK | Save
  • Percutaneous drainage is useful in biliary obstruction due to metastatic colorectal cancer
    Meeting Abstract

    Bae, S. Y.; Brown, K.; Getrajdman, G.; Brody, L.; Saltz, L.; Kurtz, R. C.
    Gastroenterology (2000)

    Fulltext@MSK | Save
  • The integration of new drugs into treatment regimens for breast cancer
    Meeting Abstract

    Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Weekly (W) herceptin (H) and taxol (T) for metastatic breast cancer (MBC): Correlation of response rate to HER2 immunophenotype (immunohistochemistry (IHC)) and gene amplification (fluorescent in-situ hybridization (FISH))
    Meeting Abstract

    Fornier, M.; Seidman, A. D.; Esteva, F.; Tan, L.; Kaptain, S.; Bach, A.; Arroyo, C. D.; Hortobagyi, G.; Norton, L.; Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Vascular endothelial growth factor (VEGF) and type 1 VEGF receptor (FLT-1) are highly expressed in Russian papillary thyroid cancers
    Meeting Abstract

    Tuttle, R. M.; Patel, A.; Francis, G.; Davis, S.; Kopecky, K.; Lushnikov, E.; Abrosimov, A.; Troshin, V.; Tsyb, A.; Fenton, C.
    Endocrine Journal (2000)

    Fulltext@MSK | Save
  • Activation of the ret/PTC oncogene in papillary thyroid cancer from Russian children exposed to radiation following the Chernobyl accident
    Meeting Abstract

    Tuttle, R. M.; Fenton, C.; Lukes, Y.; Davis, S.; Kopecky, K.; Reinhardt, B.; Lushnikov, E.; Abrosimov, A.; Troshin, V.; Tsyb, A.; more...
    Endocrine Journal (2000)

    Fulltext@MSK | Save
  • Chemotherapy dose, schedule, and the modern treatment of primary breast cancer
    Meeting Abstract

    Norton, L.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Phase I trial of yttrium-90-HuM195 (anti-CD33) in myeloid leukemia: Potential for myeloablation
    Meeting Abstract

    Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Hamacher, K. A.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2000)

    Fulltext@MSK | Save